Epidermal growth factor receptor is highly expressed in a number of human tumours (Coussens et al, 1985; Yamamoto et al, 1986; Salomon et al, 1995), and many clinical trials of EGFR-targeted therapies have been going on. The gene discussed is EGFR; the disease is neoplasm.